MelissaABurnsMD

Pediatric Hematology & Oncology • Boston, MA

Pediatric Hematology/Oncology Boston Childrens Hospital

Join to view full profile

Dr. Burns is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Burns' full profile

Already have an account?

Office
450 Brookline Ave
Boston, MA 02215
Phone+1 617-632-3442

Fax+1 617-632-4410
Is this information wrong?

Education & Training

Children's Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2012 - 2015
Children's Hospital/Boston Medical CenterResidency, Pediatrics, 2009 - 2012
New York Medical CollegeClass of 2009

Certifications & Licensure

MA State Medical License 2012 - 2024
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

Activity of the MEK inhibitor trametinib in a patient with a BRAF mutation persisting from T-lymphoblastic lymphoma through lineage switch to CNS acute myeloid leukemia.
Wallace Bourgeois, Edward Yang, Roberto Chiarle, Melissa Burns> ;Pediatric Blood & Cancer. 2024 Jun 1
Outcome for Children and Young Adults With T-Cell ALL and Induction Failure in Contemporary Trials.
Elizabeth A Raetz, Paola Rebora, Valentino Conter, Martin Schrappe, Meenakshi Devidas, Gabriele Escherich, Chihaya Imai, Barbara De Moerloose, Kjeld Schmiegelow, Melis...> ;Journal of Clinical Oncology. 2023 Nov 10
6 citations
JAK3 mutations and mitochondrial apoptosis resistance in T-cell acute lymphoblastic leukemia.
Kimberly Bodaar, Natsuko Yamagata, Anais Barthe, Jack Landrigan, Triona Ni Chonghaile, Melissa Burns, Kristen E Stevenson, Meenakshi Devidas, Mignon L Loh, Stephen P H...> ;Leukemia. 2022 Jun 1
Corrigendum to: Identification of prognostic factors in childhood T-cell acute lymphoblastic leukemia: Results from DFCI ALL Consortium Protocols 05-001 and 11-001 (Pe...
Melissa A. Burns, Andrew E. Place, Kristen E. Stevenson, Alejandro Gutierrez, Suzanne J. Forrest, Yana Pikman, Lynda M. Vrooman, Marian H. Harris, Olga K. Weinberg, Sa...> ;Pediatric Blood & Cancer. 2021 Mar 1
30 citations
Molecular basis of ETV6-mediated predisposition to childhood acute lymphoblastic leukemia.
Rina Nishii, Rebekah Baskin-Doerfler, Wentao Yang, Ninad Oak, Xujie Zhao, Wenjian Yang, Keito Hoshitsuki, Mackenzie Bloom, Katherine Verbist, Melissa A. Burns, Zhenhua...> ;Blood. 2021 Jan 21
23 citations
Identification of prognostic factors in childhood T-cell acute lymphoblastic leukemia: Results from DFCI ALL Consortium Protocols 05-001 and 11-001.
Melissa A. Burns, Andrew E. Place, Kristen E. Stevenson, Alejandro Gutierrez, Suzanne J. Forrest, Yana Pikman, Lynda M. Vrooman, Marian H. Harris, Sarah K. Hunt, Jane ...> ;Pediatric Blood & Cancer. 2021 Jan 1
17 citations
Fanconi-BRCA pathway mutations in childhood T-cell acute lymphoblastic leukemia.
Gayle P. Pouliot, James Degar, Laura Hinze, Bose Kochupurakkal, Chau D. Vo, Melissa A. Burns, Lisa A. Moreau, Chirag Ganesa, Justine E. Roderick, Sofie Peirs, Björn Me...> ;Plos One. 2019 Nov 13
18 citations
Prohibitin is a prognostic marker and therapeutic target to block chemotherapy resistance in Wilms' tumor.
Michael V. Ortiz, Saima Ahmed, Melissa A. Burns, Anton G. Henssen, Travis J. Hollmann, Ian C. MacArthur, Shehana Gunasekera, Lyvia Gaewsky, Gary Bradwin, Jeremy Ryan, ...> ;JCI Insight. 2019 Aug 8
30 citations
PRC2 loss induces chemoresistance by repressing apoptosis in T cell acute lymphoblastic leukemia.
Ingrid M. Ariës, Kimberly Bodaar, Salmaan Karim, Triona Ni Chonghaile, Laura Hinze, Melissa A. Burns, Maren Pfirrmann, James Degar, Jack T Landrigan, Sebastian T. Balb...> ;The Journal of Experimental Medicine. 2018 Dec 3
43 citations
Hedgehog pathway mutations drive oncogenic transformation in high-risk T-cell acute lymphoblastic leukemia.
Melissa A. Burns, Zi Wei Liao, Natsuko Yamagata, Gayle P. Pouliot, Kristen E. Stevenson, Donna Neuberg, Aaron R. Thorner, Matthew D. Ducar, Emily A. Silverman, Stephen...> ;Leukemia. 2018 Mar 20
50 citations
Genomic DNA transposition induced by human PGBD5
Anton G. Henssen, Elizabeth Henaff, Eileen Jiang, Amy Eisenberg, Julianne R. Carson, Camila M. Villasante, Mondira Ray, Eric Still, Melissa Burns, Jorge Gandara, Cédri...> ;Elife. 2015 Sep 25
13 citations
Pregait balance rehabilitation in acute stroke patients.
Noel Rao, Donna Zielke, Sarah Keller, Melissa Burns, Asha Sharma, Richard Krieger, Alexander S. Aruin> ;International Journal of Rehabilitation Research. Internationale Zeitschrift Fur Rehabilitationsforschung. Revue Internationale De Recherches De Readaptation. 2013 Jun 1
188 citations
Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy.
Jinyan Du, Paula Bernasconi, Karl R. Clauser, D. R. Mani, Stephen P. Finn, Rameen Beroukhim, Melissa A. Burns, Bina Julian, Xiao P. Peng, Haley Hieronymus, Rebecca L. ...> ;Nature Biotechnology. 2009 Jan 1
26 citations
Reduction of spinning sidebands in proton NMR of human prostate tissue with slow high-resolution magic angle spinning.
Melissa A. Burns, Jennifer L. Taylor, Chin-Lee Wu, Andrea G. Zepeda, Anthony Bielecki, David G. Cory, Leo L. Cheng> ;Magnetic Resonance in Medicine. 2005 Jul 1
120 citations
Metabolic characterization of human prostate cancer with tissue magnetic resonance spectroscopy.
Leo L. Cheng, Melissa A. Burns, Jennifer L. Taylor, Wenlei He, Elkan F. Halpern, W. Scott McDougal, Chin-Lee Wu> ;Cancer Research. 2005 Apr 15
33 citations
Quantitative pathology in tissue MR spectroscopy based human prostate metabolomics.
Melissa A. Burns, Wenlei He, Chin-Lee Wu, Leo L. Cheng> ;Technology in Cancer Research & Treatment. 2004 Dec 1
Join now to see all